Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death

被引:165
|
作者
Dalrymple, Lorien S. [1 ]
Katz, Ronit [2 ]
Kestenbaum, Bryan [3 ]
Shlipak, Michael G. [4 ,5 ]
Sarnak, Mark J. [6 ]
Stehman-Breen, Catherine [7 ]
Seliger, Stephen [8 ]
Siscovick, David [9 ]
Newman, Anne B. [10 ,11 ]
Fried, Linda [10 ,11 ,12 ]
机构
[1] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Vet Affairs Med Ctr, Med Serv, Gen Internal Med Sect, San Francisco, CA 94121 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[6] Tufts Med Ctr, Dept Med, Boston, MA USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
[8] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[9] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[10] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA
[11] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA
[12] VA Pittsburgh Hlth Care Syst, Renal Sect, Pittsburgh, PA USA
关键词
renal disease; cardiovascular disease; clinical epidemiology; CARDIOVASCULAR EVENTS; OLDER-ADULTS; MORTALITY; OUTCOMES; POPULATION;
D O I
10.1007/s11606-010-1511-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Among older adults with chronic kidney disease (CKD), the comparative event rates of end-stage renal disease (ESRD) and cause-specific death are unknown. To compare the rates of ESRD, cardiovascular and non-cardiovascular death and examine risk factors for ESRD and all-cause mortality in Cardiovascular Health Study (CHS) participants. The CHS is a longitudinal cohort study of community-dwelling adults aged 65 years and older. 1,268 participants with an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m(2) were followed until the time of first event (ESRD, cardiovascular or non-cardiovascular death) or until March 31, 2003. The outcomes were ESRD, cardiovascular- and non-cardiovascular death. Rates of each event were calculated, and a Cox Proportional Hazards Model with a competing risk framework was used to examine risk factors for ESRD as compared with death. Predictors included age, gender, race, BMI, hypertension, diabetes, cardiovascular disease, heart failure, tobacco use, eGFR, and total cholesterol. During 9.7 years of follow-up, 5% of the cohort progressed to ESRD, and 61% of the cohort died. The rate (per 100 person-years) was 0.5 for ESRD and 6.8 for all-cause mortality (3.0 for cardiovascular and 3.8 for non-cardiovascular mortality). In the competing risk framework, lower eGFR, male gender, African-American race, and higher BMI were associated with an increased risk of ESRD. Older adults with CKD are 13-fold more likely to die from any cause than progress to ESRD and are 6-fold more likely to die from cardiovascular causes than develop ESRD.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [31] The burden of cardiovascular disease in patients with chronic kidney disease and in end-stage renal disease
    Zoccali, Carmine
    [J]. HEMODIALYSIS: FROM BASIC RESEARCH TO CLINICAL TRIALS, 2008, 161 : 63 - 67
  • [32] Risk of death versus end-stage renal disease in patients with CKD without diabetes
    不详
    [J]. Nature Clinical Practice Nephrology, 2008, 4 (8): : 409 - 410
  • [33] Periodontal Disease in Chronic Kidney Disease and End-Stage Renal Disease Patients: A Review
    Ariyamuthu, Venkatesh K.
    Nolph, Karl D.
    Ringdahl, Bruce E.
    [J]. CARDIORENAL MEDICINE, 2013, 3 (01) : 71 - 78
  • [34] Risk Stratification and Treatment of Coronary Disease in Chronic Kidney Disease and End-Stage Kidney Disease
    Shroff, Gautam R.
    Chang, Tara I.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (06) : 582 - 599
  • [35] Preventive health care in chronic kidney disease and end-stage renal disease
    Devasmita Choudhury
    Cynthia Luna-Salazar
    [J]. Nature Clinical Practice Nephrology, 2008, 4 : 194 - 206
  • [36] Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease
    Ramesh, Mayur S.
    Yee, Jerry
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2019, 26 (01) : 30 - 34
  • [37] Treatment of osteoporosis in chronic kidney disease and end-stage renal disease.
    Miller P.D.
    [J]. Current Osteoporosis Reports, 2005, 3 (1) : 5 - 12
  • [38] Energy Balance in Advanced Chronic Kidney Disease and End-Stage Renal Disease
    Cuppari, Lillian
    Ikizler, Talat Alp
    [J]. SEMINARS IN DIALYSIS, 2010, 23 (04) : 373 - 377
  • [39] Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease
    Nakhoul, Georges N.
    Huang, Haiquan
    Arrigain, Susana
    Jolly, Stacey E.
    Schold, Jesse D.
    Nally, Joseph V., Jr.
    Navaneethan, Sankar D.
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2015, 41 (06) : 456 - 463
  • [40] Preventive health care in chronic kidney disease and end-stage renal disease
    Choudhury, Devasmita
    Luna-Salazar, Cynthia
    [J]. NATURE CLINICAL PRACTICE NEPHROLOGY, 2008, 4 (04): : 194 - 206